Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas L Davis

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Neuromodulation : Journal of the International Neuromodulation Society|July 21, 2021
BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's DiseaseCaryl E Sortwell, Mallory L Hacker, David Luke Fischer, et al.
Journal of the National Medical Association|August 10, 2006
Depression and intelligence in patients with Parkinson's disease and deep-brain stimulationCourtney R Schadt, Katie L Cox, Michael G Tramontana, et al.
Neurology|July 1, 2020
Deep brain stimulation in early-stage Parkinson disease: Five-year outcomesMallory L Hacker, Maxim Turchan, Lauren E Heusinkveld, et al.
Journal of Parkinson'S Disease|January 2, 2022
Outcomes Impacting Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-Carbidopa Intestinal GelNorbert Kovács, Lars Bergmann, Marieta Anca-Herschkovitsch, et al.
Journal of Parkinson'S Disease|August 14, 2013
Pilot study assessing the feasibility of applying bilateral subthalamic nucleus deep brain stimulation in very early stage Parkinson's disease: study design and rationaleDavid Charles, Christopher Tolleson, Thomas L Davis, et al.
Movement Disorders Clinical Practice|October 11, 2021
DUOGLOBE: One-Year Outcomes in a Real-World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's DiseaseDavid G Standaert, Jason Aldred, Marieta Anca-Herschkovitsch, et al.
Journal of Parkinson'S Disease|January 24, 2015
Neuropsychological effects of deep brain stimulation in subjects with early stage Parkinson's disease in a randomized clinical trialMichael G Tramontana, Anna L Molinari, Peter E Konrad, et al.
Journal of Parkinson'S Disease|March 12, 2016
Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson's DiseaseMallory L Hacker, Amanda D Currie, Anna L Molinari, et al.
Parkinsonism & Related Disorders|August 26, 2015
Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson's diseaseMallory L Hacker, James Tonascia, Maxim Turchan, et al.
Journal of Parkinson'S Disease|June 11, 2023
Levodopa Carbidopa Intestinal Gel in Advanced Parkinson's Disease: DUOGLOBE Final 3-Year ResultsK Ray Chaudhuri, Norbert Kovács, Francesco E Pontieri, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Neuromodulation : Journal of the International Neuromodulation Society|July 21, 2021
BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's DiseaseCaryl E Sortwell, Mallory L Hacker, David Luke Fischer, et al.
Journal of the National Medical Association|August 10, 2006
Depression and intelligence in patients with Parkinson's disease and deep-brain stimulationCourtney R Schadt, Katie L Cox, Michael G Tramontana, et al.
Neurology|July 1, 2020
Deep brain stimulation in early-stage Parkinson disease: Five-year outcomesMallory L Hacker, Maxim Turchan, Lauren E Heusinkveld, et al.
Journal of Parkinson'S Disease|January 2, 2022
Outcomes Impacting Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-Carbidopa Intestinal GelNorbert Kovács, Lars Bergmann, Marieta Anca-Herschkovitsch, et al.
Journal of Parkinson'S Disease|August 14, 2013
Pilot study assessing the feasibility of applying bilateral subthalamic nucleus deep brain stimulation in very early stage Parkinson's disease: study design and rationaleDavid Charles, Christopher Tolleson, Thomas L Davis, et al.
Movement Disorders Clinical Practice|October 11, 2021
DUOGLOBE: One-Year Outcomes in a Real-World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's DiseaseDavid G Standaert, Jason Aldred, Marieta Anca-Herschkovitsch, et al.
Journal of Parkinson'S Disease|January 24, 2015
Neuropsychological effects of deep brain stimulation in subjects with early stage Parkinson's disease in a randomized clinical trialMichael G Tramontana, Anna L Molinari, Peter E Konrad, et al.
Journal of Parkinson'S Disease|March 12, 2016
Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson's DiseaseMallory L Hacker, Amanda D Currie, Anna L Molinari, et al.
Parkinsonism & Related Disorders|August 26, 2015
Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson's diseaseMallory L Hacker, James Tonascia, Maxim Turchan, et al.
Journal of Parkinson'S Disease|June 11, 2023
Levodopa Carbidopa Intestinal Gel in Advanced Parkinson's Disease: DUOGLOBE Final 3-Year ResultsK Ray Chaudhuri, Norbert Kovács, Francesco E Pontieri, et al.
Pageof 6